Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence-Reference-Cited by-同舟云学术

Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence

Published:2010-10 Issue:10 Volume:85 Page:945-948
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Rajkumar S. Vincent,Kyle Robert A.,Buadi Francis K.

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Prevalence of monoclonal gammopathy of undetermined significance;Kyle;N Engl J Med,2006

2. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management;Kyle;Leukemia,2010

3. A long-term study of prognosis of monoclonal gammopathy of undetermined significance;Kyle;N Engl J Med,2002

4. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients;Bida;Mayo Clin Proc,2009

5. Prevention of progression in monoclonal gammopathy of undetermined significance;Rajkumar;Clin Cancer Res,2009

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies in Smoldering Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Current Status and Future Directions;Pharmaceuticals;2024-07-06

2. The Skin and Disorders of the Haematopoietic and Immune Systems;Rook's Textbook of Dermatology;2024-03-19

3. Monoclonal Gammopathies of Undetermined Significance and Abnormal Serum Protein Rates Prevelance in Blood Donors: For Improved Transfusion Safety;Global Journal of Transfusion Medicine;2024-01

4. Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance;Hemato;2023-11-01

5. Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review;Diagnostics;2023-07-10